People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cornerstone Therapeutics Inc | — | Pharmaceuticals | Series B | $30.0M | $1.0B | 2012 |
KENNETH R. MCBEAN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside KENNETH R. MCBEAN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| JAMES A. HARPER | 1 | 3 |
| ANTON GIORGIO FAILLA | 1 | 2 |
| VINCENT T. MORGUS | 1 | 2 |
| Craig A. Collard | 1 | 2 |
| MICHAEL A. HEFFERNAN | 1 | 1 |
| LAURA D. SHAWVER | 1 | 1 |
| ROBERT M. STEPHAN | 1 | 1 |
| CHRISTOPHER G. CODEANNE | 1 | 1 |
| ANDREW K. W. POWELL | 1 | 1 |
| MARCO M. VECCHIA | 1 | 1 |
| ALAN T. ROBERTS | 1 | 1 |
| MICHAEL D. ENRIGHT | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.